Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale

The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017-2022), and give a perspective on the future trends and direction that nanomedicine research is taking.

Automated summary

The new and unique possibilities offered by nanomaterials have had a significant impact on biomedicine, particularly in disease treatment and diagnosis as well as targeted drug delivery. Technological advancements in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of various nanomedicines and novel applications. Research in nanodiagnostics and nanomedicines is actively pursued in Spain, with exponential discoveries in various disease areas. This review provides an overview of the current state of nanotechnology, specifically nanoparticles, for disease treatment in Spain (2017-2022), and offers insights into future trends and directions in nanomedicine research.